Spatial Mass Spectrometry Industry expansion is set to result in a CAGR of 15.3% for Tumor Cell Iden
At a CAGR of 15.3% from 2022 to 2032, the global spatial mass spectrometry industry is anticipated to increase from US$ 254.8 million in 2022 to US$ 1.0 billion by 2032. The rising incidence of cancer, the rising demand for omics-based clinical trials, and the rising investment in the pharmaceutical industry are all...
Source: pharmiweb.com